Differentiating agents in the treatment of leukemia and myelodysplastic syndromes.

[1]  H. Tilly,et al.  Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  R. Berger,et al.  RETINOIC ACID THERAPY FOR PROMYELOCYTIC LEUKAEMIA , 1989, The Lancet.

[3]  Zhen-yi Wang,et al.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.

[4]  A. Ganser,et al.  Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase-I/II trial. , 1988, Onkologie.

[5]  A. Berrebi,et al.  Review of clinical and haematological response to low‐dose cytosine arabinoside in acute myeloid leukaemia , 1987, European journal of haematology.

[6]  J. Gris,et al.  Present results of the treatment of myelodysplastic syndromes with low-dose cytosine arabinoside. Preliminary results of a cooperative protocol (38 patients) and review of the literature. , 1987, Acta haematologica.

[7]  A. Ho,et al.  Combination of low-dose cytarabine and 13-cis retinoic acid in the treatment of myelodysplastic syndromes. , 1987, Leukemia research.

[8]  B. Vogelstein,et al.  Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia. , 1986, The New England journal of medicine.

[9]  K. Cantell,et al.  Interferon alpha in the treatment of hairy cell leukemia , 1986, Cancer.

[10]  F. Sigaux,et al.  Treatment of hairy cell leukemia with recombinant alpha interferon: I. Quantitative study of bone marrow changes during the first months of treatment. , 1986, Blood.

[11]  J. Abita,et al.  Structure-activity relationships of aromatic retinoids on the differentiation of the human histiocytic lymphoma cell line U-937. , 1986, Leukemia research.

[12]  F. Sigaux,et al.  Treatment of leukemia with low dose Ara-C: a study of 159 cases. , 1985, Haematology and blood transfusion.

[13]  F. Sigaux,et al.  Low‐dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients , 1985, Cancer.

[14]  H. Tilly,et al.  Does treatment with ARA-C in low dosage cause differentiation of leukemic cells? , 1983, Blood.

[15]  M. Housset,et al.  Small doses of ARA‐C in the treatment of acute myeloid leukaemia: differentiation of myeloid leukaemia cells? , 1982, British journal of haematology.